Tag Archives: United States

FDA terminates emergency use authorization of hydroxychloroquine for Covid-19

The US Food and Drug Administration has revoked its emergency use authorization for the drugs hydroxychloroquine and chloroquine for the treatment of Covid-19. After reviewing the current research available on the drugs, the FDA determined that the drugs do not meet “the statutory criteria” for emergency use authorization as they …

Read More »